Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation

Therapeutic Apheresis and Dialysis

Volumn 9, Issue 4, 2005, Pages 285-291

  Kozaki, Koichi ^a,b   Egawa, Hiroto ^a   Kasahara, Mureo ^a   Oike, Fumitaka ^a   Yoshizawa, Atsushi ^a   Fukatsu, Atsushi ^a   Tanaka, Koichi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Box 606 8507 ^*  (Japan)

Author keywords

ABO incompatible; Apheresis; Living donor liver transplantation; Plasmapheresis

Indexed keywords

BLOOD GROUP ANTIBODY; CYCLOPHOSPHAMIDE; GABEXATE MESILATE; METHYLPREDNISOLONE; PROSTAGLANDIN E1; RITUXIMAB; STEROID; TACROLIMUS;

ANTIBODY PRODUCTION; APHERESIS; ARTICLE; BLOOD CLOTTING; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP TYPING; GRAFT REJECTION; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; PLASMAPHERESIS; PREOPERATIVE CARE; PRIORITY JOURNAL; SPLENECTOMY;

EID: 28044471483     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2005.00304.x     Document Type: Article

References (5)

1. Kiuchi T, Inomata Y, Uemoto S et al. Living-donor liver transplantation in Kyoto, 1997. In: Cecka M, Terasaki PI, eds. Clinical Transplants 1997. Los Angeles: UCLA Tissue Typing Laboratory, 1997;191-8.
2. Egawa H, Oike F, Buhler L et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 2004;77:403-11.
3. Kozaki K, Kasahara M, Oike F et al. Apheresis therapy for living-donor liver transplantation. Ther Apher Dial 2002;6:478-83.
4. Demetris AJ, Jaffe R, Tzakis A et al. Antibody-mediated rejection of humoral orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988;132:489-502.
5. Tanabe M, Shimazu M, Wakabayashi G et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2002;73:1959-61.